Newspaper article from our research archive:

Medistem to Present on Its Progress in Its Menstrual Derived Stem Cell Program ERC ; BioFinance 2008 Presentation to Highlight ERC Clinical Path

SAN DIEGO, CA and SCOTTSDALE, AZ--(Marketwire - May 06, 2008) - Medistem Laboratories, Inc. (OTCBB: MDSM), a biotechnology company dedicated to commercialization of its novel, universal donor, stem cell population, the Endometrial Regenerative Cell (ERC), is pleased to announce its upcoming presentation at the BioFinance 2008 meeting.

Medistem will review its recent progress in the development of an "off the shelf" product for the treatment of critical limb ischemia, an advanced form of peripheral vascular disease. The company will also provide an overview of its current scientific and regulatory strategy, as well as its ongoing research efforts.

Thomas Ichim, CEO of Medistem, commented, ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!